Abstract
MCH1R antagonists have been used to treat several diseases, such as obesity, depression and anxiety. In this study, we have performed several pharmacophore-based CoMFA studies for a series of 2,4,6 substituted quinolines as potent antagonists of MCH1R. Significant statistical results were obtained (q2 = 0.78, r2 = 0.99), indicating the high internal consistency of the 3D model generated, as well as its predictive power for untested compounds. The 3D model was externally validated employing a test set and the predicted biological values showed good agreement with experimental results. Important insights on the molecular interactions between the studied ligands and the MCH1R receptor, inferred from the 3D contour maps, were obtained and can be useful for the design of new structurally related analogs with improved binding affinity.
Keywords: MCH1R, Quinolines, Molecular Modeling, 3D QSAR, CoMFA
Medicinal Chemistry
Title:Identification of Structural and Electronic Features for a Series of MCH1R Antagonists
Volume: 9 Issue: 1
Author(s): Danielle C. Silva, Adriano D. Andricopulo, Emmanuela F. de Lima and Káthia M. Honório
Affiliation:
Keywords: MCH1R, Quinolines, Molecular Modeling, 3D QSAR, CoMFA
Abstract: MCH1R antagonists have been used to treat several diseases, such as obesity, depression and anxiety. In this study, we have performed several pharmacophore-based CoMFA studies for a series of 2,4,6 substituted quinolines as potent antagonists of MCH1R. Significant statistical results were obtained (q2 = 0.78, r2 = 0.99), indicating the high internal consistency of the 3D model generated, as well as its predictive power for untested compounds. The 3D model was externally validated employing a test set and the predicted biological values showed good agreement with experimental results. Important insights on the molecular interactions between the studied ligands and the MCH1R receptor, inferred from the 3D contour maps, were obtained and can be useful for the design of new structurally related analogs with improved binding affinity.
Export Options
About this article
Cite this article as:
C. Silva Danielle, D. Andricopulo Adriano, F. de Lima Emmanuela and M. Honório Káthia, Identification of Structural and Electronic Features for a Series of MCH1R Antagonists, Medicinal Chemistry 2013; 9 (1) . https://dx.doi.org/10.2174/1573406411309010022
DOI https://dx.doi.org/10.2174/1573406411309010022 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytochromes P450 in Brain: Function and Significance
Current Drug Metabolism Neurosarcoidosis
Current Neuropharmacology Antidepressant Properties of Substance P Antagonists: Relationship to Monoaminergic Mechanisms?
Current Drug Targets - CNS & Neurological Disorders Novel Asthma Therapies: A Review
Current Drug Therapy Acne Vulgaris: an Inflammatory Disease Even Before the Onset of Clinical Lesions
Inflammation & Allergy - Drug Targets (Discontinued) Chemokines and Brain Functions
Current Drug Targets - Inflammation & Allergy Depression and Cardiovascular Disease: Role of Nitric Oxide
Cardiovascular & Hematological Agents in Medicinal Chemistry Epoxyeicosatrienoic Acids as a Therapeutic Target for Nephropathy Associated with Diabetes and Hypertension
Current Hypertension Reviews Interaction between Gastric and Upper Small Intestinal Hormones in the Regulation of Hunger and Satiety: Ghrelin and Cholecystokinin Take the Central Stage
Current Protein & Peptide Science 5-HT7 Receptors
Current Drug Targets - CNS & Neurological Disorders Leptin as a Cardiac Pro-Hypertrophic Factor and its Potential Role in the Development of Heart Failure
Current Pharmaceutical Design Anti-obesity Agents: A Focused Review on the Structural Classification of Therapeutic Entities
Current Topics in Medicinal Chemistry From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews Regulation of Gastric Nesfatin-1/NUCB2
Current Pharmaceutical Design Neuroimaging of Consciousness and Sleep Spindles
Recent Patents on Medical Imaging The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue Syndrome
Current Pharmaceutical Design Suppression of TLR Signaling by Targeting TIR domain-Containing Proteins
Current Protein & Peptide Science The Fetal Origins of Obesity: Early Origins of Altered Food Intake
Endocrine, Metabolic & Immune Disorders - Drug Targets Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment
Current Pharmaceutical Design Melatonin in Antinociception: Its Therapeutic Applications
Current Neuropharmacology